AJP - Renal Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol 292: F1479-F1489, 2007. First published January 16, 2007; doi:10.1152/ajprenal.00460.2006
0363-6127/07 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
292/5/F1479    most recent
00460.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via ISI Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schmidt, C.
Right arrow Articles by Bucher, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schmidt, C.
Right arrow Articles by Bucher, M.

Cytokine-mediated regulation of urea transporters during experimental endotoxemia

Christoph Schmidt,1 Klaus Höcherl,2 and Michael Bucher1

Departments of 1Anesthesiology and 2Physiology, Regensburg University, Regensburg, Germany

Submitted 20 November 2006 ; accepted in final form 8 January 2007

Acute renal failure (ARF) is a frequent complication of sepsis and has a high mortality. Sepsis-induced ARF is known to be associated with significant impairment of tubular capacity. However, the pathogenesis of endotoxemic tubular dysfunction with failure of urine concentration is poorly understood. Urea plays an important role in the urinary concentrating mechanism and expression of the urea transporters UT-A1, UT-A2, UT-A3, UT-A4, and UT-B is essential for tubular urea reabsorption. The present study attempts to assess the regulation of renal urea transporters during severe inflammation in vivo. Lipopolysaccharide-(LPS)-injected mice presented with reduced glomerular filtration rate, fractional urea excretion, and inner medulla osmolality associated with a marked decrease in expression of all renal urea transporters. Similar alterations were observed after application of tumor necrosis factor (TNF)-{alpha}, interleukin (IL)-1beta, interferon (IFN)-{gamma}, or IL-6. LPS-induced downregulation of urea transporters was not affected in knockout mice with deficient TNF-{alpha}, IL-receptor-1, IFN-{gamma}, or IL-6. Glucocorticoid treatment inhibited LPS-induced increases of tissue TNF-{alpha}, IL-1beta, IFN-{gamma}, or IL-6 concentration, diminished LPS-induced renal dysfunction, and attenuated the downregulation of renal urea transporters. Renal ischemia induced by renal artery clipping did not influence the expression of urea transporters. Our data demonstrate that renal urea transporters are downregulated by severe inflammation, which likely accounts for tubular dysfunction. Furthermore, they suggest that the downregulation of renal urea transporters during LPS-induced ARF is mediated by proinflammatory cytokines and is independent from renal ischemia because of sepsis-induced hypotension.

lipopolysaccharide; glucocorticoids



Address for reprint requests and other correspondence: M. Bucher, Dept. of Anesthesiology, Regensburg Univ., 93042 Regensburg, Germany (e-mail: michael.bucher{at}klinik.uni-regensburg.de)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.